• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Alembic Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 40294.0
  • ISIN : INE901L01018
959.05 -19 (-1.93%)
  • As on 03 Aug 2025 (EOD)

  • Today’s Low

    947.60

  • Today’s High

    978.75

  • Open

    977.90

  • Perv Close

    977.90

  • 52W Low

    725.20

  • 52W High

    1,303.90

Key Indicators

  • P/E(TTM)

    38.52

  • Mar.Cap (₹Cr.)

    18,851.39

  • Div & Yield %

    1.15

  • Book Value(₹)

    264.28

  • Debt-Equity Ratio

    -1.93

  • AGM Date

    01-Aug-2025

  • EPS

    24.87

  • P/E Ratio

    38.52

Financials Ratios

  • Debt-Equity Ratio

    0.13

  • Mar.Cap (₹Cr.)

    18,851.39

  • RONW (%)

    13.40

  • ROCE (%)

    12.93

Score Board

  • Equity (₹ in Cr.)

    39.31

  • BV (₹)

    264.30

  • Sales( ₹ in Cr.)

    6,032.63

  • NP (in Cr.)

    488.93

  • NP Var(%)

    -27.0

  • Div%

    550.0

  • CPS (₹)

    39.00

  • EPS (₹)

    24.90

  • Traded Value (₹ in Lakhs)

    18,831.73

  • 52 Week High

    1,303.90

  • 52 Week Low

    725.20

  • Price BSE

    958.0

  • Price NSE

    959.00

  • Market Capital( in Cr.)

    18,831.73

  • P/C Ratio

    24.60

  • P/E Ratio

    38.50

  • Price Vs.BV

    24.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 6,032.63 5,874.06 5,149.00 5,035.41 5,066.89 4,132.55
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 6,032.63 5,874.06 5,149.00 5,035.41 5,066.89 4,132.55
Other Income 60.75 504.88 3.54 51.14 83.90 134.75
Stock Adjustments 268.54 52.36 -72.84 -19.85 160.65 176.50
Total Income 6,361.92 6,431.30 5,079.70 5,066.70 5,311.44 4,443.80
EXPENDITURE :            
Raw Materials 2,057.31 1,852.71 1,587.29 1,482.36 1,464.67 1,222.39
Power and Fuel Cost 179.67 173.32 151.19 120.50 118.31 97.43
Employee Cost 1,466.57 1,335.91 1,094.82 1,062.30 976.13 806.37
Other Manufacturing Expenses 388.12 327.87 357.21 324.10 344.44 291.44
Selling and Administration Expenses 1,269.90 1,191.89 1,173.00 1,088.67 848.55 661.00
Miscellaneous Expenses 38.21 519.76 48.31 28.82 26.07 37.52
Employee Benefit Expenses 1,466.57 1,335.91 1,094.82 1,062.30 976.13 806.37
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 5,399.78 5,401.46 4,411.82 4,106.75 3,778.17 3,116.15
Operating Profit 962.14 1,029.84 667.88 959.95 1,533.27 1,327.65
Interest 76.47 54.47 49.00 17.02 12.98 25.19
Gross Profit 885.67 975.37 618.88 942.93 1,520.29 1,302.46
Depreciation 277.08 271.14 272.95 284.92 182.55 135.67
Profit Before Tax 608.59 704.23 345.93 658.01 1,337.74 1,166.79
Current Tax 105.47 37.75 -0.80 114.46 241.20 197.39
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit 503.12 666.48 346.73 543.55 1,096.54 969.40
Extraordinary Items 14.19 0.99 0.05 2.81 5.20 -7.06
Adjusted Net Profit 488.93 665.49 346.68 540.74 1,091.34 976.46
Adjustment below Net Profit 0.00 3,494.43 0.00 -76.31 -114.90 -51.00
P & L Balance brought forward 4,160.91 0.00 2,632.89 2,440.83 1,709.19 1,296.49
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 216.22 0.00 -672.07 275.19 250.00 525.97
P & L Balance carried down 4,447.81 4,160.91 3,651.69 2,632.88 2,440.83 1,688.92
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 550.00 550.00 400.00 500.00 700.00 500.00
Dividend Per Share(Rs) 11.00 11.00 8.00 10.00 14.00 10.00
Earnings Per Share-Unit Curr 25.60 33.91 17.64 27.65 55.79 51.43
Earnings Per Share(Adj)-Unit Curr 25.60 33.91 17.64 27.65 55.79 51.43
Book Value 264.30 249.75 224.59 269.16 259.57 177.51
Book Value(Adj)-Unit Curr 264.30 249.75 224.59 269.16 259.57 177.51

Shareholding Pattern

  • Promoter Group

    69.68%

  • Public Share Holding

    30.33%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 1,006,980 1,006,980.00 1,006,980 1,006,980
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 1,006,980 0.51 1,006,980 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 126,306,299 64.26 126,306,299 15
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 9,641,976 4.91 9,641,976 11
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 135,948,275 69.16 135,948,275 26
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 53,650 0.03 38,550 7
Foreign Bank 3,250 0.00 3,250 1
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 7,784,464 3.96 7,784,464 146
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 13,785,522 7.01 13,785,522 8
Mutual Funds / UTI 17,795,370 9.05 17,795,370 20
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 722,086 0.37 722,086 10
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 40,144,342 20.42 40,129,242 192
2] Non Institution
Bodies Corporate 335,555 0.17 327,355 340
Clearing Members 0 0.00 0 0
Directors of their Relatives 2,409,078 1.23 2,409,078 4
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 895,623 0.46 895,248 1,968
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,236,520 0.63 1,236,520 6
Individuals holding nominal share capital up to Rs. 1 lakh 12,542,919 6.38 11,593,673 84,906
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 2,043,832 1.04 2,042,992 1,570
Sub Total 19,463,527 9.90 18,504,866 88,794
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 196,563,124 100.00 195,589,363 89,013

Company Background

Alembic Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Alembic Pharmaceuticals Ltd
  • BSE Code : 40294.0
  • ISIN : INE901L01018

  • Incorporation Year

    2010

  • Registered Office

    Alembic Road
    , Vadodara,
    Gujarat-390003

  • Telephone

    91-0265-2280550

  • FAX

    91-0265-2282506

  • Chairman

    Chirayu R Amin

  • Managing Director

    Pranav Amin

  • Company Secretary

    Manisha Saraf

  • Auditor

    K C Mehta & Co LLP/KKC & Associates LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Link Intime India Pvt Ltd
    B-102&103 Shangrila,
    Complex First Floor,Akota
    Mumbai - Vadodara - 390 020

Alembic Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Alembic Pharma 958.05 6,080.51 6,032.63 37.42 11.40
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10